Effect of MGuard Net Protective Stent on the Release of Troponin I in Patients With Acute Coronary Syndromes A Randomized Controlled Trial
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F11%3A7166" target="_blank" >RIV/00064203:_____/11:7166 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11130/11:7166
Výsledek na webu
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21828944" target="_blank" >http://www.ncbi.nlm.nih.gov/pubmed/21828944</a>
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Effect of MGuard Net Protective Stent on the Release of Troponin I in Patients With Acute Coronary Syndromes A Randomized Controlled Trial
Popis výsledku v původním jazyce
This study was designed to determine whether the treatment of patients with unstable angina pectoris or non-Q-wave myocardial infarction with a stent containing a protection net to prevent coronary microembolization affects the severity of biomarker release. The MGuard stent (InspireMD, Tel Aviv, Israel) was designed as a plaque/thrombus-trapping device, using a conventional bare metal stent covered with an ultrathin, flexible mesh net. We hypothesized that this stent would partly eliminate distal embolization and decrease subsequent troponin I (TnI) release. Forty-six acute coronary syndrome patients referred for percutaneous coronary intervention (PCI) were included and randomized in this study. Serum concentrations of TnI were measured prior to, aswell as 24 and 48 hours after, the PCI procedure. Technical success was 95% and 100% in the MGuard group and non-MGuard group, respectively. A transient no-reflow phenomenon was observed in one interventional procedure in each group of pa
Název v anglickém jazyce
Effect of MGuard Net Protective Stent on the Release of Troponin I in Patients With Acute Coronary Syndromes A Randomized Controlled Trial
Popis výsledku anglicky
This study was designed to determine whether the treatment of patients with unstable angina pectoris or non-Q-wave myocardial infarction with a stent containing a protection net to prevent coronary microembolization affects the severity of biomarker release. The MGuard stent (InspireMD, Tel Aviv, Israel) was designed as a plaque/thrombus-trapping device, using a conventional bare metal stent covered with an ultrathin, flexible mesh net. We hypothesized that this stent would partly eliminate distal embolization and decrease subsequent troponin I (TnI) release. Forty-six acute coronary syndrome patients referred for percutaneous coronary intervention (PCI) were included and randomized in this study. Serum concentrations of TnI were measured prior to, aswell as 24 and 48 hours after, the PCI procedure. Technical success was 95% and 100% in the MGuard group and non-MGuard group, respectively. A transient no-reflow phenomenon was observed in one interventional procedure in each group of pa
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FA - Kardiovaskulární nemoci včetně kardiochirurgie
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/NT11401" target="_blank" >NT11401: Význam spánkové apnoe v patofyziologii hypertrofické kardiomyopatie</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2011
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
International Heart Journal
ISSN
1349-2365
e-ISSN
—
Svazek periodika
52
Číslo periodika v rámci svazku
4
Stát vydavatele periodika
JP - Japonsko
Počet stran výsledku
4
Strana od-do
203-206
Kód UT WoS článku
000296130400002
EID výsledku v databázi Scopus
—